Skip to main content
. 2019 Aug 1;13(2):430. doi: 10.4081/oncol.2019.430

Figure 3.

Figure 3.

Developing personalized therapies for patients with pancreatic cancer. Sequencing of excised tumor or biopsies may one day allow physicians to categorize a patient’s cancer into therapeutic groups based on expression of tumor and immunologic markers. This will allow for the intelligent selection and design of combination immunotherapies for more successful treatment.